Cost‐Effectiveness of Parenteral Nutrition Containing ω‐3 Fatty Acids in Hospitalized Adult Patients From 5 European Countries and the US
Open Access
- 26 July 2020
- journal article
- research article
- Published by Wiley in Journal of Parenteral and Enteral Nutrition
- Vol. 45 (5) , 999-1008
Abstract
Background: ω‐3 Fatty acid (FA)–containing parenteral nutrition (PN) is associated with improvements in patient outcomes and with reductions in hospital length of stay (HLOS) vs standard PN regimens (containing non–ω‐3 FA lipid emulsions). We present a cost‐effectiveness analysis of ω‐3 FA–containing PN vs standard PN in 5 European countries (France, Germany, Italy, Spain, UK) and the US.Methods: This pharmacoeconomic model was based on estimates of ω‐3 efficacy reported in a recent meta‐analysis and data from country‐specific sources. It utilized a probabilistic discrete event simulation model to compare ω‐3 FA–containing PN with standard PN in a population of critically ill and general ward patients. The influence of model parameters was evaluated using probabilistic and deterministic sensitivity analyses.Results: Overall costs were reduced with ω‐3 FA–containing PN in all 6 countries compared with standard PN, ranging from €1741 (±€1284) in Italy to €5576 (±€4193) in the US. Expenses for infections and HLOS were lower in all countries for ω‐3 FA–containing PN vs standard PN, with the largest cost differences for both in the US (infection: €825 ± €4001; HLOS: €4879 ± €1208) and the smallest savings in the UK for infections and in Spain for HLOS (€63 ± €426 and €1636 ± €372, respectively).Conclusion: This cost‐effectiveness analysis in 6 countries demonstrates that the superior clinical efficacy of ω‐3 FA–containing PN translates into significant decreases in mean treatment cost, rendering it an attractive cost‐saving alternative to standard PN across different healthcare systems.Keywords
This publication has 45 references indexed in Scilit:
- n-3 fatty acid-enriched parenteral nutrition regimens in elective surgical and ICU patients: a meta-analysisCritical Care, 2012
- Hospital length of stay and probability of acquiring infectionInternational Journal of Pharmaceutical and Healthcare Marketing, 2010
- Hospital costs of central line-associated bloodstream infections and cost-effectiveness of closed vs. open infusion containers. The case of Intensive Care Units in ItalyCost Effectiveness and Resource Allocation, 2010
- Rationale and use of n-3 fatty acids in artificial nutritionProceedings of the Nutrition Society, 2010
- Attributable Costs of Enterococcal Bloodstream Infections in a Nonsurgical Hospital CohortInfection Control & Hospital Epidemiology, 2010
- Comparative effects of olive oil-based and soyabean oil-based emulsions on infection rate and leucocyte count in critically ill patients receiving parenteral nutritionBritish Journal of Nutrition, 2007
- Fish oil after abdominal aorta aneurysm surgeryEuropean Journal of Clinical Nutrition, 2007
- Evaluation of clinical safety and beneficial effects of a fish oil containing lipid emulsion (Lipoplus, MLF541): Data from a prospective, randomized, multicenter trial*Critical Care Medicine, 2007
- Use of parenteral nutrition in hospitals in the North of EnglandJournal of Human Nutrition and Dietetics, 2007
- Omega-3 fatty acids improve the diagnosis-related clinical outcome*Critical Care Medicine, 2006